Synthetic Biotechnology Company Amyris Reveals Progress In Ingredients Supply Transaction The post Synthetic Biotechnology Company Amyris Reveals Progress In Ingredients Supply Transaction appeared on BitcoinEthereumNews.com. Amyris Inc (NASDAQ: AMRS), a synthetic biotechnology company, has completed the negotiation of key financial and business terms for the exclusive rights to supply two of its ingredients. The transaction has an expected… Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Filed under: News - @ December 27, 2022 8:10 pm